What is the recommended starting dose, titration schedule, and safety precautions for initiating mirtazapine in an adult patient?

Mirtazapine Initiation in Adults

Start mirtazapine at 15 mg once daily, taken in the evening before sleep, and if inadequate response occurs, increase to 30 mg daily after 1-2 weeks, with a maximum dose of 45 mg daily. 1

Starting Dose and Administration

• Initial dose: 15 mg once daily at bedtime 1
• This is the FDA-approved starting dose and is recommended across clinical guidelines 2
• Evening administration is preferred due to sedative effects 1

Titration Schedule

If patients fail to respond adequately to 15 mg:

• Increase to 30 mg daily after 1-2 weeks 1
• Evidence supports this early dose escalation: patients who didn't improve by week 1 on 15 mg showed significantly better outcomes when increased to 30 mg (34.7% remission vs 14.3% staying at 15 mg, p=0.003) 3

Further dose increases:

• Maximum dose is 45 mg daily 1
• However, increasing beyond 30 mg shows limited additional benefit—no significant differences were found between staying at 30 mg versus increasing to 45 mg in non-responders 3
• Practical recommendation: Most patients will respond optimally at 30 mg; reserve 45 mg for treatment-resistant cases

Critical timing: Wait at least 1-2 weeks between dose changes to properly evaluate response 1

Essential Safety Precautions

Before Starting Treatment

Screen for bipolar disorder - Obtain personal and family history of mania, hypomania, or bipolar disorder before initiating 1. Mirtazapine can precipitate manic episodes in susceptible patients 1.

MAOI interactions - Absolute contraindication:

• Do not use if patient is taking an MAOI or stopped one within 14 days 1
• Wait 14 days after stopping mirtazapine before starting an MAOI 1
• Includes linezolid and IV methylene blue 1

Drug Interactions Requiring Dose Adjustment

Reduce mirtazapine dose when co-administering: 1

• Strong CYP3A4 inhibitors (ketoconazole, clarithromycin) - reduce by 51.1% with fluvoxamine, 26.9% with paroxetine 4
• Cimetidine
• Specific guidance: Use 15 mg daily with fluvoxamine; 22.5-30 mg daily with paroxetine 4

Increase mirtazapine dose when co-administering: 1

• Strong CYP3A inducers (carbamazepine, phenytoin, rifampin)

Patient-Specific Considerations

Obesity (BMI ≥28 kg/m²):

• Reduces clearance by 29.4% 4
• Consider starting at lower end of dosing range (22.5-30 mg maintenance dose) 4

Renal or hepatic impairment:

• Consider dose reduction 2, 1
• Monitor closely for adverse effects

Older adults:

• Mirtazapine is a preferred agent in elderly patients 2
• Start at standard 15 mg dose (guidelines don't recommend 50% reduction for mirtazapine specifically, unlike some other antidepressants)
• Monitor for increased sedation and falls risk

Monitoring for Serious Adverse Effects

White blood cell count:

• Rare but serious risk of agranulocytosis and neutropenia 1
• Instruct patients to report immediately: fever, sore throat, flu-like symptoms, chills, mouth/nose sores, infections 1
• Consider baseline CBC, though not mandated by FDA labeling

Serotonin syndrome risk:

• Particularly when combined with other serotonergic agents (SSRIs, SNRIs, triptans, tramadol, fentanyl, St. John's Wort) 1
• Symptoms: agitation, confusion, tachycardia, tremor, muscle rigidity, hyperthermia, autonomic instability 1
• This is a medical emergency requiring immediate discontinuation

Angle-closure glaucoma:

• Screen for eye pain, vision changes, eye redness/swelling 1
• Consider ophthalmology referral for at-risk patients before starting

QT prolongation:

• Caution in patients with cardiac history or family history of QT prolongation 1

Common Adverse Effects to Counsel Patients About

• Sedation/drowsiness (23% vs 14% placebo) - typically improves at therapeutic doses ≥15 mg 2, 5
• Weight gain and increased appetite (10% vs 1% placebo) 2, 1
• Dry mouth (25% vs 16% placebo) 2
• Notably lacks sexual dysfunction seen with SSRIs 6

Important counseling point: Warn patients not to drive or operate machinery until they know how mirtazapine affects them 1. Avoid alcohol and benzodiazepines during treatment 1.

Discontinuation

Never stop abruptly - taper gradually to avoid withdrawal symptoms 1. Abrupt discontinuation can cause adverse reactions including anxiety, agitation, and flu-like symptoms.

Clinical Context

Mirtazapine is considered a first-line second-generation antidepressant with a favorable adverse effect profile 2. Its dual noradrenergic and serotonergic mechanism (NaSSA) may provide faster onset of action compared to SSRIs 6, 5, with some studies showing significant improvement as early as week 1 5. It is particularly useful when anxiety and sleep disturbance accompany depression 6, 7, 8.